Synthesis of hyaluronic acid by human peritoneal mesothelial cells: Effect of cytokines and dialysate

Peritoneal Dialysis International

Volumn 16, Issue 4, 1996, Pages 374-378

  Breborowicz, Andrzej ^a   Korybalska, Katarzyna ^a   Grzybowski, Andrzej ^a   Wieczorowska Tobis, Katarzyna ^a   Martis, Leo ^b   Oreopoulos, Dimitrios G ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cytokines; Effluent dialysate; Human peritoneal mesothelial cells; Hyaluronic acid

Indexed keywords

CYTOKINE; DIANEAL; HYALURONIC ACID; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; HUMAN; HUMAN CELL; MESOTHELIUM CELL; MONOLAYER CULTURE; NORMAL HUMAN; PERITONEUM CELL; PRIORITY JOURNAL; SERUM;

EID: 0029814317     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601600410     Document Type: Article

References (25)

1. Laurent TG, Fraser RE, Hyaluronan. FASEB J 1992; 6:2397-2404.
2. Ohashi Y, Honda A, Iwai T, et al. Stimulatory effect of vanadate on hyaluronic acid synthesis in mesothelial cells from rabbit peritoneum. Biochem Int 1988; 16:293-302.
3. Yung S, Coles GA, Williams JD, et al. The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994; 46:527-33.
4. Hamura Y, Ito A, Okada Y,et al. Hyaluronic acid metabolism in inflamed mesenterium of guinea pig Res Commun Chem Pathol Pharmacol 1989; 66:311-27.
5. Davies M, Stylianou E, Yung S, et al. Proteoglycans of CAPD-dialysate fluid and mesothelium. In: Coles GA, Davies M, Williams J, eds. CAPD: host defense, nutrition and ultrafiltration. Contrib Nephrol 1990; 85:134-41.
6. Lipkin EN, Forbes MA, Cooper EH, et al. Hyaluronic acid metabolism and its clinical significance in patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993; 8:357-60.
7. Beelen RHJ, van der Meulen J, Verbrugh H,et al. CAPD, a permanent state of peritonitis: a study on peroxidase activity. In: Maher JF, Winchester JF, eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Associates, 1986:524-30.
8. Honda A, Iwai T, Mori Y. Insulin-like growth factor-I (IGF-I) enhances hyaluronic acid synthesis in rabbit pericardium. Biochem Biophys Acta 1989; 1014:305-12.
9. Heldin P, Asplund T, Ytterberg D, et al. Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells. Biochem J 1992; 283:213-6.
10. Postlethwaite AE, Smith GN, Lachman LB,et al. Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by Interleukin-1. J Clin Invest 1989; 83:629-36.
11. Sampson PM, Rochester CL, Freundlich B,et al. Cytokine regulation of human lung fibroblast (hyaluronic acid) production. J Clin Invest 1992; 90:1492-1503.
12. Breborowicz A, Karon J, Korybalska K,et al. Functional properties of mesothelial cells after prolonged exposure to dialysate effluent. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1995; 11:15-8.
13. Laurent UBG, Reed RK. Turnover of hyaluronan in the tissues. Adv Drug Deliv Rev 1991; 7:237-56.
14. Pannekeet MM, Zemel D, Koomen GCM.,et al. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int 1995; 15:217-25.
15. Bos HJ, Struijk DG, Tuk CW, et al. Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence. Nephron 1991; 59:508-9.
16. Lewis S, Holmes C. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1991; 11:14-21.
17. Greenwald RA, May WW. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum 1980; 223:455-61.
18. Suzuki Y, Yamaguchi T. Effects of hyaluronic acid on macrophage phagocytosis and active oxygen release. Agents Actions 1993; 38:32-7.
19. Akatsuka M, Yamamoto Y, Tobetto K,et al. Suppressive effect of hyaluronic acid on elastase release from rat peritoneal leukocytes. J Pharm Pharmacol 1993;45:110-4.
20. Weigel PH., Fuller Gm., LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in early events during the inflammatory response and wound healing. J Theor Biol 1986; 119:219-26.
21. Adzick NS, Longaker MT. Scarless fetal healing: therapeutic implications. Ann Surg 1992; 215:3-7.
22. Breborowicz A, Wieczorowska K, Martis L, et al. Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats. Nephron 1994; 35:410-6.
23. Wieczorowska K, Breborowicz A, Martis L,et al. Protective effect of hyaluronic acid against peritoneal injury. Perit Dial Int 1995; 15:81-3.
24. Gambaro G, Fracasso A, Re G, et al. Glycosaminoglycans improve peritoneal transport and fibrosis in rats with peritoneal sclerosis induced by diethylphatalate. J Am Soc Nephrol 1994; 5:448.
25. Bazzato G, Fracasso A, Gambaro G, Baggio B. Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis. Lancet 1995; 346:740-1.